Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Omission of concurrent chemoradiation after a response to neoadjuvant chemotherapy in locally advanced rectal cancer with a synchronous liver metastasis
British Journal of Radiology, 10/29/07
Craven, I., et al. - A case study that illustrates the potential risk of omitting radiation following a good response to neoadjuvant systemic chemotherapy in locally advanced rectal cancer with a synchronous liver metastasis.
Methods- An overview of potential risk of omitting radiation following a good response to neoadjuvant systemic chemotherapy
- There is clear evidence to support the use of pre-operative concurrent chemo-radiotherapy (CRT) in locally advanced rectal cancer
- In the UK, most pts are selected for treatment if the resection margin is predicted to be involved
- The selection criteria used includes primary tumours that threaten the resection margins on high-resolution pelvic MRI and low tumours requiring abdominoperineal excision
- There is no consensus, however, to guide the treatment of pts who present with advanced rectal disease and synchronous, potentially resectable, metastatic disease
Related Articles
Prediction of outcome of patients with metastatic breast cancer: evaluation with prognostic factors and Nottingham prognostic index
Supportive Care in Cancer, 11/19/09
Relevance Score: 67%
Successful outcome after resection of liver metastasis arising from an extraadrenal retroperitoneal paraganglioma that appeared 9 years after surgical excision of the primary lesion
International Journal of Clinical Oncology, 10/30/09
Relevance Score: 67%
CD10 enhances metastasis of colorectal cancer by abrogating the antitumoral effect of methionine-enkephalin in the liver
Gut, 10/22/09
Relevance Score: 67%
Surgical management of colorectal liver metastases
Community Oncology, 10/09/09
Relevance Score: 67%
Repeat Curative Intent Liver Surgery is Safe and Effective for Recurrent Colorectal Liver Metastasis: Results from an International Multi-institutional Analysis
Journal of Gastrointestinal Surgery, 10/08/09
Relevance Score: 67%
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Polo-like kinase inhibitors: an emerging opportunity for cancer therapeutics
Expert Opinion on Investigational Drugs, 12/16/09
Plerixafor for Stem Cell Mobilization in Patients with Non-Hodgkin's Lymphoma and Multiple Myeloma
Annals of Pharmacotherapy, 12/16/09
Clinically-Staged T3N0 Rectal Cancer: Is Preoperative Chemoradiotherapy the Optimal Treatment
Annals of Surgical Oncology, 12/16/09
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
The efficacy and safety of telaprevir ? a new protease inhibitor against hepatitis C virus
Expert Opinion on Investigational Drugs, 12/16/09
Clinically-Staged T3N0 Rectal Cancer: Is Preoperative Chemoradiotherapy the Optimal Treatment
Annals of Surgical Oncology, 12/16/09
Patient attitudes towards and experiences with an intervention programme to reduce chronic acid-suppressing drug intake in primary care
The European Journal of General Practice, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


